AINewsnow

Isomorphic Labs in talks to raise $5bn at $50bn valuation

This story is from 2026-11-05. It is preserved in the archive; the latest stories are on the live feed.

Isomorphic Labs, the drug discovery company spun out of Google DeepMind, is in talks to raise about $5bn in a round that would value it at roughly $50bn, Bloomberg reported.

Read the full story at The Next Web ↗

Timeline · 1 report

  1. 2026-11-05 13:57 · The Next Web
    Isomorphic Labs in talks to raise $5bn at a $50bn valuation, Bloomberg reports

More stories

  1. Claude Code drives wave of community-built apps, tools and workflows — DEV Community — AI
  2. Google buys Crusoe's Wyoming data center site, plans $17 billion investment — Bloomberg AI
  3. OpenAI says GPT-6 Cyber will first launch to a limited number of customers in its Daybreak Red program and has found 81+ "novel" vulnerabilities in Firefox (Djohnson/CyberScoop) — Techmeme
  4. Gemini Omni 1.2 Flash: Fast and cost-effective with longer clips — Google AI Blog
  5. Parents sue Google, alleging teen used Gemini on school Chromebook to plan suicide — Reuters AI
  6. Big Tech and green groups in talks over US data center guardrails — Economic Times Tech
  7. Google and Microsoft among those signing up to OpenAI's plan for a new website crawling standard — including opting-out of internet scraping — TechRadar AI
  8. Google's Wyoming site acquisition puts the engineering handoff in focus — DEV Community — AI

Get the daily brief of stories like this at 6:30 every morning →